| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.94B | 3.10B | 2.33B | 2.30B | 1.48B | 1.08B |
| Gross Profit | 22.36M | 71.64M | 148.80M | 285.51M | 142.80M | 91.41M |
| EBITDA | 29.36M | 77.03M | 163.47M | 294.84M | 168.50M | 115.65M |
| Net Income | -66.50M | -16.04M | 54.92M | 138.23M | 72.47M | 29.09M |
Balance Sheet | ||||||
| Total Assets | 1.61B | 1.68B | 1.66B | 1.08B | 971.94M | 969.90M |
| Cash, Cash Equivalents and Short-Term Investments | 375.55M | 352.62M | 300.71M | 92.47M | 50.08M | 54.44M |
| Total Debt | 369.73M | 338.27M | 262.97M | 165.30M | 51.17M | 82.30M |
| Total Liabilities | 545.87M | 584.85M | 535.95M | 355.88M | 418.55M | 466.66M |
| Stockholders Equity | 965.11M | 985.37M | 1.02B | 573.79M | 457.93M | 400.56M |
Cash Flow | ||||||
| Free Cash Flow | -19.90M | 13.82M | -43.95M | 199.74M | 44.27M | -21.69M |
| Operating Cash Flow | 35.60M | 96.86M | 104.46M | 318.82M | 94.88M | 50.62M |
| Investing Cash Flow | -222.25M | -268.86M | -71.06M | -150.12M | -58.70M | -77.35M |
| Financing Cash Flow | -43.37M | 2.49M | 204.95M | -139.06M | -44.28M | 12.71M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
69 Neutral | HK$1.07B | 8.30 | 3.36% | 7.85% | -5.37% | 25.20% | |
64 Neutral | HK$283.20M | 15.53 | 7.30% | 2.00% | 29.04% | -1.55% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
56 Neutral | HK$625.71M | -18.00 | -14.53% | ― | 0.35% | -153.95% | |
54 Neutral | HK$727.48M | -5.84 | -6.64% | ― | 2.76% | -293.57% | |
54 Neutral | HK$780.84M | -26.25 | -1.52% | 5.55% | 0.37% | -331.54% | |
48 Neutral | HK$59.70M | -0.04 | ― | ― | -15.10% | 31.07% |
Henan Jinyuan Hydrogenated Chemicals Co., Ltd. has convened an extraordinary general meeting for 30 January 2026 in Hong Kong to seek shareholder approval for board and supervisory committee changes. Shareholders will vote on the election and remuneration of Mr. Xu Fenglei as a non-executive director and of Mr. Zhou Feng as a shareholder representative supervisor, with both terms aligned to the current board and supervisory committee tenures. The company has emphasized the use of proxy voting to avoid the need for physical attendance, and has outlined registration, documentation and identification requirements for H-shareholders, underscoring governance formalities and potential incremental changes in the company’s oversight structure.
The most recent analyst rating on (HK:2502) stock is a Hold with a HK$0.50 price target. To see the full list of analyst forecasts on Henan Jinyuan Hydrogenated Chemicals Co., Ltd. Class H stock, see the HK:2502 Stock Forecast page.
Henan Jinyuan Hydrogenated Chemicals Co., Ltd. announced that non-executive director Wang Kaibao and shareholder representative supervisor Wu Zhiqiang will resign following the upcoming extraordinary general meeting, with Wang also stepping down from the audit committee and as chairman of the strategy committee, though both departing executives reported no disagreements with the board. To fill the vacancies and maintain continuity in governance and strategic oversight, the board is proposing the appointment of Henan Jinma Energy deputy chairman and senior engineer Xu Fenglei as a non-executive director, and Zhou Feng as a shareholder representative supervisor, both to serve until the end of the current board and supervisory committee term without additional remuneration, reinforcing the company’s links with its controlling shareholder and its focus on safety, environmental protection and carbon-neutrality expertise.
The most recent analyst rating on (HK:2502) stock is a Hold with a HK$0.50 price target. To see the full list of analyst forecasts on Henan Jinyuan Hydrogenated Chemicals Co., Ltd. Class H stock, see the HK:2502 Stock Forecast page.
Henan Jinyuan Hydrogenated Chemicals Co., Ltd. announced that shareholders approved all six ordinary resolutions at its extraordinary general meeting held on 31 December 2025, endorsing a series of new framework agreements covering the sale of by-products, purchases of crude coking coal gas, crude benzene and coke granule coal gas raw materials, miscellaneous procurement, and the Yugang Coking supply arrangements, together with their respective annual caps. The resolutions, passed by a 100% poll among the 40 million H shares voted, formalise the company’s key related-party and supply-chain transactions for coming periods, providing clearer visibility on raw material sourcing and by-product sales, although the controlling shareholder Jinma Energy and its associates, holding 75% of issued shares, abstained from voting in line with listing rules.
The most recent analyst rating on (HK:2502) stock is a Hold with a HK$0.50 price target. To see the full list of analyst forecasts on Henan Jinyuan Hydrogenated Chemicals Co., Ltd. Class H stock, see the HK:2502 Stock Forecast page.
Henan Jinyuan Hydrogenated Chemicals Co., Ltd. has announced an extraordinary general meeting (EGM) to be held on December 31, 2025, in Hong Kong. The meeting will address several resolutions concerning new framework agreements for the sale and purchase of various chemical products and raw materials. Shareholders are encouraged to use proxy forms to vote on these resolutions, which could impact the company’s operational agreements and market positioning.
The most recent analyst rating on (HK:2502) stock is a Hold with a HK$0.50 price target. To see the full list of analyst forecasts on Henan Jinyuan Hydrogenated Chemicals Co., Ltd. Class H stock, see the HK:2502 Stock Forecast page.
Henan Jinyuan Hydrogenated Chemicals Co., Ltd. announced the closure of its register of members from December 24 to December 31, 2025, to determine eligibility for attending and voting at the upcoming extraordinary general meeting (EGM) on December 31, 2025. This meeting will address Non-exempt Continuing Connected Transactions, and shareholders must ensure their share transfer documents are lodged by December 23, 2025. This announcement is significant for stakeholders as it outlines the procedural requirements for participation in the EGM, potentially impacting shareholder engagement and decision-making processes.
The most recent analyst rating on (HK:2502) stock is a Hold with a HK$0.50 price target. To see the full list of analyst forecasts on Henan Jinyuan Hydrogenated Chemicals Co., Ltd. Class H stock, see the HK:2502 Stock Forecast page.
Henan Jinyuan Hydrogenated Chemicals Co., Ltd. announced a delay in the dispatch of a circular related to Non-exempt Continuing Connected Transactions. The circular, initially expected by December 9, 2025, will now be sent by December 16, 2025, due to the need for additional time to finalize its contents.
The most recent analyst rating on (HK:2502) stock is a Hold with a HK$0.50 price target. To see the full list of analyst forecasts on Henan Jinyuan Hydrogenated Chemicals Co., Ltd. Class H stock, see the HK:2502 Stock Forecast page.
Henan Jinyuan Hydrogenated Chemicals Co., Ltd. has announced the renewal of its continuing connected transactions through New Framework Agreements with Jinma Energy and Yugang Coking. These agreements, effective from January 2026 to December 2028, involve both exempt and non-exempt transactions under Hong Kong’s Listing Rules, necessitating various reporting and approval processes. The renewal aims to ensure the continuation of business operations with these connected entities, impacting the company’s financial and operational strategies.
The most recent analyst rating on (HK:2502) stock is a Hold with a HK$0.50 price target. To see the full list of analyst forecasts on Henan Jinyuan Hydrogenated Chemicals Co., Ltd. Class H stock, see the HK:2502 Stock Forecast page.